-
Diagnostics World Brief | Veracyte has entered into a long-term strategic collaboration with Johnson & Johnson Innovation and the Lung Cancer Initiative at Johnson & Johnson to advance the development and commercialization of novel diagnostic tests to detect lung cancer at its earliest stages, when the disease is most treatable. Veracyte announced the collaboration yesterday.
Jan 4, 2019
-
Diagnostics World | As we head into 2019, we at Diagnostics World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2018.
Jan 2, 2019
-
Fast Company |
IBM has created a tiny sensor that attaches to your fingernail and monitors things like pressure, motion, and grip strength. The tiny sensor can monitor cardiovascular health.
Dec 21, 2018
-
Diagnostics World | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including BaseHealth, ChromaCode, MaxQ, and more.
Dec 19, 2018
-
Diagnostics World Contributed Commentary | Exosome research has been a relatively niche field for some years now, but today there is growing enthusiasm among a much broader community about the diagnostic, prognostic, and therapeutic potential of these vesicles. Following on the heels of circulating tumor cells and cell-free DNA, exosomes represent the next great opportunity for liquid biopsy applications.
Dec 18, 2018
-
Diagnostics World Contributed Commentary | Major factors contributing to the acceleration of personalized healthcare in recent years come from advances in high-performance computing (HPC), data analytics, machine learning, and artificial intelligence, enabling scientists now to perform the most sophisticated simulations in genomics, proteomics, and many other fields, using methods like genome analysis, molecular dynamics, and more general computer aided analysis methods widely applied and proven in other areas of scientific and engineering modeling. We demonstrate the impact of computer simulations on personalized health care and present two research projects aiming at living heart and brain simulations.
Dec 13, 2018
-
The New York Times |
Malaria quickly kills toddlers. But rapid diagnostic tests, a new suppository drug and bicycle ambulances can buy enough time to get stricken children to hospitals.
Dec 10, 2018
-
Diagnostics World Contributed Commentary | Growing evidence suggests biological markers of Alzheimer’s disease may begin forming decades before an individual begins experiencing symptoms. Because of this, researchers are finding ways to detect the disease earlier and with more accuracy than standard diagnostic methods.
Dec 10, 2018
-
Diagnostics World Brief | Insight Genetics has launched Insight TNBCtype, a new test for categorizing triple negative breast cancer (TNBC) tumors into distinct molecular subtypes through its wholly owned CLIA- and CAP-accredited lab, Insight Molecular Labs. Insight TNBCtype is the first CLIA-validated assay for TNBC molecular subtyping, and the company believes it will enable prospective clinical trials with pharmaceutical, biotechnology, and academic medical institutions and advance targeted therapies for TNBC patients, addressing a significant unmet need in oncology today.
Dec 7, 2018
-
Diagnostics World | Quest Diagnostics, in partnership with Humana, MultiPlan, and UnitedHealth Group’s Optum and UnitedHealthcare, have launched a pilot program that applies blockchain technology to improve data quality and reduce administrative costs associated with changes to healthcare provider demographic data.
Dec 5, 2018
-
Diagnostics World News Brief | Biocartis announced it has entered into an agreement with AstraZeneca. The goal of the agreement will be to obtain faster lung cancer molecular diagnostic biomarker results in Europe.
Nov 30, 2018